Tata India Pharma & Healthcare Fund-Direct Plan-Growth
Fund House: Tata Mutual Fund| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 28-12-2015 |
| Asset Class: Equity |
| Benchmark: NIFTY Pharma TRI |
| TER: 1.07% As on (29-09-2026) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 1,511.49 Cr As on 30-09-2026(Source:AMFI) |
| Turn over: 94.2% | Exit Load: If redeemed before 30 Day; Exit Load is 0.25%; |
36.9906
0.02 (0.0603%)
12.83%
Benchmark: 14.42%
PERFORMANCE
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Investment Objective
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Current Asset Allocation (%)
Indicators
| Standard Deviation | 16.77 |
| Sharpe Ratio | 0.79 |
| Alpha | -0.84 |
| Beta | 0.99 |
| Yield to Maturity | - |
| Average Maturity | - |
PEER COMPARISON
| Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
|---|---|---|---|---|---|---|
| Tata India Pharma & Healthcare Fund-Direct Plan-Growth | 28-12-2015 | 2.8 | 1.35 | 17.39 | 13.3 | 14.4 |
Scheme Characteristics
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
39.25%
Others
0.28%
Large Cap
26.01%
Mid Cap
34.46%
